Key molecules like ATP, ADP, and adenosine, acting through purinergic receptors (P1 and P2), have been implicated in the regulation of endocrine functions, including insulin secretion, glucose ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...